Posted: Tuesday, October 28, 2025
NCCN Patient Resources
CAR T-Cell Therapies: Idecabtagene Vicleucel and Ciltacabtagene Autoleucel
(UPDATE) Daratumumab
Update Carfilzomib Kyprolis
(UPDATE) Ixazomib
Teclistamab-cqyv